Correlation Between Caribou Biosciences and Regeneron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Caribou Biosciences and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Regeneron Pharmaceuticals.
Diversification Opportunities for Caribou Biosciences and Regeneron Pharmaceuticals
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Caribou and Regeneron is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Regeneron Pharmaceuticals go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Regeneron Pharmaceuticals
Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Regeneron Pharmaceuticals. In addition to that, Caribou Biosciences is 3.85 times more volatile than Regeneron Pharmaceuticals. It trades about -0.02 of its total potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about 0.0 per unit of volatility. If you would invest 72,047 in Regeneron Pharmaceuticals on September 23, 2024 and sell it today you would lose (1,862) from holding Regeneron Pharmaceuticals or give up 2.58% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Caribou Biosciences vs. Regeneron Pharmaceuticals
Performance |
Timeline |
Caribou Biosciences |
Regeneron Pharmaceuticals |
Caribou Biosciences and Regeneron Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Caribou Biosciences and Regeneron Pharmaceuticals
The main advantage of trading using opposite Caribou Biosciences and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Regeneron Pharmaceuticals vs. Fate Therapeutics | Regeneron Pharmaceuticals vs. Sana Biotechnology | Regeneron Pharmaceuticals vs. Caribou Biosciences | Regeneron Pharmaceuticals vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |